From what I have read so far, cultivating transgenic herd to produce theraupetic proteins takes long time. The flip side of it is these proteins can be mass produced and if the market for them is big (which it is), the company can make great deal of money.
I am for one, looking for 2009 end to have GTCB pps >$10 (all based on ongoing partnerships and pipeline progress).
Market Data 
Markets 
AI
